Source · Select Committees · Health and Social Care Committee
Recommendation 19
19
Deferred
Paragraph: 113
Vulnerable individuals lack sufficient time to consider non-surgical cosmetic procedure decisions.
Conclusion
The dangers posed by non-surgical cosmetic procedures in vulnerable groups have been evident throughout the inquiry. The new licensing regime provides an opportunity to ensure that anyone planning to undertake a non-surgical cosmetic procedure has the time and space to consider their decision, and weigh up the risks and benefits. It is clear this is not currently the case for everyone in that position.
Government Response Summary
The government explained the current regulation of dermal fillers as products by the MHRA, mentioning that the MHRA intends to introduce more stringent rules for aesthetic and non-medical products, but stated there are no plans to make dermal fillers prescription-only.
Paragraph Reference:
113
Government Response
Deferred
HM Government
Deferred
The government recognises that there are significant physical and psychological risks that cosmetic fillers (commonly known as ‘dermal fillers’) present to members of the public. Filler products can be used for medical treatment or for aesthetic purposes. In England, the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 prohibits the availability of ‘Botox’ and dermal fillers to under-18s for cosmetic purposes. Currently, a dermal filler may be regulated either as a general product, a medicine or a medical device, depending on its composition and intended use. Fillers classified as general products are not subject to licensing or manufacturing controls, and do not need a prescription to be obtained. The Medicines and Healthcare products Regulatory Agency ( MHRA ) is responsible for the regulation of medical devices, and intends to bring in more stringent rules for certain aesthetic and non-medical products, including dermal fillers, under the UK medical devices regulations. There are no current plans for MHRA to make dermal fillers prescription only. Unlike Botox, dermal fillers cannot be covered by the existing prescription-only medicine framework because they are medical devices rather than medicinal products. We strongly encourage anyone considering dermal fillers to take the time to find a reputable, insured and qualified practitioner.